Related Experiment Video
Updated: May 29, 2026
07:13
An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach
Published on: December 7, 2016
Microdevice for aqueous humor drainage Maldonado Bas - Pförtner
Arturo Maldonado-Bas1, Ana Maldonado-Junyent, Arturo Maldonado-Junyent
1Clínica de Ojos Maldonado Bas, Cordoba, Argentina. renadavid@gmail.com
Arquivos Brasileiros De Oftalmologia
|September 15, 2011
Summary
A novel microdevice effectively treats refractory glaucoma, significantly reducing intraocular pressure. This innovative glaucoma treatment shows an 87.5% success rate in a one-year study.
Area of Science:
- Ophthalmology
- Medical Devices
- Surgical Innovation
Background:
- Refractory glaucoma presents a significant challenge in intraocular pressure management.
- Existing treatments may be insufficient for certain glaucoma cases.
Purpose of the Study:
- To introduce and evaluate a novel microdevice for the treatment of refractory glaucoma.
- To analyze the efficacy and surgical technique of this new glaucoma microimplant.
Main Methods:
- A prospective study involving 16 eyes with refractory glaucoma.
- Surgical implantation of the microdevice followed by a one-year follow-up period.
- Intraocular pressure measurements and statistical analysis (averages, percentages, confidence bands, ANOVA).
Main Results:
- Preoperative average intraocular pressure was 32.81 mmHg; post-surgical average at one year was 12.43 mmHg.
- An average reduction of 20.38 mmHg in intraocular pressure was observed.
- The microdevice achieved an 87.5% success rate (14 out of 16 eyes).
Conclusions:
- The microdevice demonstrates significant success in treating refractory glaucoma.
- This innovative approach offers a promising solution for patients with challenging glaucoma.
